logo

For the Inventor, By the Inventor

Burnaby, Canada

Alectos Therapeutics Inc.

Calculating rank
USPTO Granted Patents = 19

% Expired Patents = 63.2



Forward Citations = 44

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Yuanxi Zhou (16 out of 40 patents)

silverMedal Ernest John McEachern (15 out of 43 patents)

bronzeMedal David Jaro Vocadlo (15 out of 22 patents)

4.  Harold G Selnick (15 out of 102 patents)

5.  Yongbao Zhu (10 out of 19 patents)

6.  Ramesh Kaul (8 out of 12 patents)

7.  Jianyu Sun (5 out of 25 patents)

8.  Kun Liu (5 out of 48 patents)

9.  Yaode Wang (4 out of 10 patents)

10.  Zhongyong Wei (4 out of 8 patents)

11.  Tong-Shuang Li (4 out of 9 patents)

12.  Changwei Mu (3 out of 8 patents)

13.  Ernest J Mceachern (3 out of 3 patents)

14.  Jiang Chang (2 out of 16 patents)

15.  Samy Cecioni (1 out of 1 patent)


19 patents:

1. 12528773 - NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF (2026-01-20),
2. 11396522 - Bis-acetal-based substrates for imaging exo-glycosidase activity (2022-07-26),
3. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof (2021-02-09),
4. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),
5. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),
6. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),
7. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),
8. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),
9. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),
10. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),
11. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),
12. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),
13. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),
14. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),
15. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),
Company Overview
Alectos Therapeutics Inc. is a biotechnology company based in Burnaby, Canada, focused on developing innovative therapeutics for the treatment of various diseases. The company specializes in drug discovery and development, leveraging advanced technologies to create novel solutions that address unmet medical needs. Alectos is particularly engaged in research related to metabolic disorders and other chronic conditions, aiming to improve patient outcomes through targeted therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

19 Patents

#24 in Burnaby

#779 in Canada

#32,726 in the World

Burnaby, CA
Burnaby, Canada

Alectos Therapeutics Inc.

Forward Citations = 44

21 inventors:

goldMedal Yuanxi Zhou (16 out of 40 patents)

silverMedal Ernest John McEachern (15 out of 43 patents)

bronzeMedal David Jaro Vocadlo (15 out of 22 patents)

4.  Harold G Selnick (15 out of 102 patents)

5.  Yongbao Zhu (10 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alectos Therapeutics Inc.. Retrieved from https://idiyas.com/company/alectos-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…